Perrigo Establishes Tax Base in $8.6B Elan Deal
July 29 (Bloomberg) -- Bloomberg News' Matthew Campbell reports that Perrigo Co. has come to an agreement to buy Irish drug company Elan Corp. for $8.6 billion, establishing a low-tax base for international expansion. He speaks on Bloomberg Television's "The Pulse."
Most Recent Videos
Italy's Padoan on French Election and Future of EU
46:22 - Italian Finance Minister Pier Carlo Padoan discusses the French elections, the future of the EU and Italy's banking industry with Bloomberg Editor-in-Chief John Micklethwait. (Source: Bloomberg)